Paired antiviral approach pushes SARS-CoV-2 toward near-complete loss of infectivity

A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus ...
GEN

Host Proteins Identified in SARS-CoV-2 Replication Pathways Reveal Drug Targets

The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...

Long-awaited anti-COVID drug is also a milestone against future viruses

Ensitrelvir represents a significant advancement in the treatment of COVID-19, setting the stage for enhanced defenses ...
The New England Journal of Medicine

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras

Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) can affect many organ systems. However, temporal changes during the coronavirus disease 2019 ...
The New England Journal of Medicine

Project NextGen — Defeating SARS-CoV-2 and Preparing for the Next Pandemic

Interview with Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2. 9m 26s Download The development of safe and ...